glp 1 in obesity GLP-1 Agonists For Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Weighing the risk of GLP-1

[40] evaluated the effects of liraglutide on cardiovascular risk biomarkers such as adiponectin, leptin, high-sensitivity C-reactive protein (hs-CRP), interleukin 6 (IL-6), tumor necrosis factor (TNF-), plasminogen activator inhibitor 1 (PAI-1), and B-type natriuretic peptide (BNP)

It does this by: Stimulating insulin production when blood sugar levels rise Slowing down glucose absorption to prevent sugar spikes Reducing glucagon secretion , which helps stabilize blood sugar This is why GLP-1 receptor agonists are used to treat type 2 diabetes , making them a game-changer for those looking to control blood sugar naturally

GLP-1s can cause hypoglycemia when combined with insulin or sulfonylureas your log is your safety net

The Physiological Reason for Nausea Why does GLP-1 cause nausea